On Wednesday July 8, 2020, Dr. David Schwartz of Innovative Science Solutions presented at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. A complimentary copy of the panel presentation is now available for download.
On Wednesday July 8, 2020, Dr. David Schwartz of Innovative Science Solutions presented at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. A complimentary copy of the panel presentation is now available for download below.
Panel Summary
The ongoing revolution in genomic science is having an impact on many facets of modern life, including toxic tort and other types of litigation. This presentation covers topics related to how genetic testing results are being used in courtrooms throughout the country, and considerations for how you might be able to use genetic testing in your trials.
Topics covered by the panel include:
Genetic Fundamentals
Obtaining Genetic Testing
Ethics Related to Genetic Testing
Costs and Types of Sequencing
Admissibility and Causation
Tracking the Science
Case Studies
The moderator of the panel was: Sandra J. Wunderlich, Tucker Ellis LLP, St. Louis, Missouri USA
Speakers on the panel were: Scott Elder, Alston & Bird, Atlanta, Georgia USA; Joshua D. Lee, Riley Safer Holmes & Cancila LLP, Chicago, Illinois USA; David H. Schwartz, PhD, Innovative Science Solutions, Inc., Morristown, New Jersey USA
Download a complimentary copy of the panel presentation by completing the form below.
Download a copy of the panel's presentation from the recent IADC meeting
Dr. David Schwartz of Innovative Science Solutions will be presenting at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. Read more
Genetic Evidence Concerning Causation for Mesothelioma 16 June 2020 at 2pm Eastern Daylight Time. Read more
Plaintiff experts having been asserting for decades that all mesotheliomas must be linked to some asbestos exposure. Indeed, this has led to the erroneous (but widespread) view that mesothelioma is a signature disease, only caused by asbestos exposure. Read more
The ToxicoGenomica team has brought genomic causation analysis into over 30 cancer cases for defendants in cases involving benzene, radiation, and asbestos (see here for a description of five of the older cases). Read more
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today
Contact us